Upon Tamoxifen-induced deletion of LATS1/2 in this model, we observed a dramatic overgrowth of cells within the mammary ducts, leading to a phenotype resembling ductal carcinoma in situ (DCIS) (Fig. 1c). The gene discussed is LATS1; the disease is ductal breast carcinoma in situ.